The medical route to market approval in the UK – the pros and cons

Products that can prove their efficacy in treating smoking addiction can pursue a medical licence route in the UK. The MHRA, Britain’s pharmaceutical regulator, is currently encouraging and supporting companies to submit medicines authorisation applications for e-cigarette products.

This route offers both advantages and disadvantages. Though quite costly and time-consuming, it enables producers and sellers to make health claims and sidestep product restrictions imposed on tobacco-related e-cigarette products.

This regulatory report from ECigIntelligence explains how the process works, and examines the pros and cons.

...
Free Sample

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ The medical route to market approval in the UK – the pros and cons ”

This file is not available, please fill the form to request your sample page:





Buy report request information:

“ The medical route to market approval in the UK – the pros and cons ”





Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.

FREE TRIAL